Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 71, Issue 1-2, 1996, Pages 145-153

  Cross, Anne H ^a   Keeling, Richard M ^a   Goorha, Salil ^a   San, Manuel ^a   Rodi, Charles ^b   Wyatt, Pamela S ^c   Manning, Pamela T ^c   Misko, Thomas P ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PFIZER INC   (United States)

^c Inflammatory Dis Res GD S   (United States)

Author keywords

competitive reverse transcriptase PCR; experimental allergic (autoimmune) encephalomyelitis; nitric oxide

Indexed keywords

MESSENGER RNA; NITRIC OXIDE SYNTHASE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ENZYME ACTIVITY; ETIOLOGY; FEMALE; GENE EXPRESSION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPINAL CORD;

ADOPTIVE TRANSFER; ANIMALS; CITRULLINE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME INDUCTION; FEMALE; GENE EXPRESSION; MICE; MICE, INBRED STRAINS; NITRIC OXIDE SYNTHASE; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPINAL CORD;

EID: 0030560858     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00147-6     Document Type: Article

References (62)

1. Al-Ramadi B.K., Meissler J.J. Jr., Huang D., Eisenstein T.K. Immunosuppression induced by nitric oxide and its inhibition by interleukin-4. Eur. J. Immunol. 22:1992;2249-2254.
2. Albina J.E., Abate J.A., Henry W.L. Jr. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of IFN-γ in the induction of the nitric oxide-synthesizing pathway. J. Immunol. 147:1991;144-148.
3. Baker D., O'Neill J.K., Turk J.L. Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis. Cell. Immunol. 134:1991;505-510.
4. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
5. Belenky S.N., Robbins R.A., Rubinstein I. Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro. J. Leuk. Biol. 53:1993;498-503.
6. Bo L., Dawson T.M., Wesselingh S., Mork S., Choi S., Kong P.A., Hanley D., Trapp B.D. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol. 36:1994;778-786.
7. Borgerding R.A., Murphy S. Expression of inducible nitric oxide synthase in cerebral endothelial cells is regulated by cytokine-activated astrocytes. J. Neurochemistry. 65:1995;1342-1347.
8. Bredt D.S., Snyder S.J. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci USA. 86:1989;9030-9033.
9. Brosnan C.F., Battistini L., Raine C.S., Dickson D.W., Casadevall A., Lee S.C. Reactive nitrogen intermediates in human neuropathology: an overview. Dev. Neurosci. 16:1994;152-161.
10. Chao C.C., Hu S., Molitor T.W., Shaskan E.G., Peterson P.K. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149:1992;2736-2741.
11. Colasanti M., Mollace V., Cundari E., Massoud R., Nistico G., Lauro G.M. The generation of nitric oxide participates in γIFN-induced MHC Class II antigen expression by cultured astrocytoma cells. Int. J. Immunopharmac. 15:1993;763-771.
12. Cross A.H., Misko T.P., Lin R.F., Hickey W.F., Trotter J.L., Tilton R.G. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93:1994;2684-2690.
13. Deng W., Thiel B., Tannenbaum C.S., Hamilton T.A., Stuehr D.J. Synergistic cooperation between T cell lymphokines for induction of the nitric oxide synthase gene in murine peritoneal macrophages. J. Immunol. 151:1993;322-329.
14. Dore-Duffy P., Donaldson J.O., Koff T., Longo M., Perry W. Prostaglandin release in multiple sclerosis: correlation with disease activity. Neurology. 36:1986;1587-1590.
15. Galea E., Feinstein D.L., Reis D.J. Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures. Proc. Natl. Acad. Sci. USA. 89:1992;10945-10949.
16. Henry Y., Ducrocq C., Drapier J.C., Servent D., Pellat C., Guissani A. Nitric oxide, a biologic effector. Electron paramagnetic resonance detection of nitrosyl-iron-protein complexes in whose cells. Eur. Biophys. J. 20:1991;1-15.
17. Heuschling P. Nitric oxide modulates γ-interferon-induced MHC class II antigen expression on rat astrocytes. J. Neuroimmunol. 57:1995;63-69.
18. Hewett S.J., Corbett J.A., McDaniel M.L., Choi D.W. Interferon-γ and interleukin-1β induce nitric oxide formation from primary mouse astrocytes. Neurosci. Lett. 164:1993;229-232.
19. Hewett S.J., Misko T.P., Keeling R.M., Behrens M.M., Choi D.W., Cross A.H. Murine encephalitogenic lymphoid cells induce nitric oxide synthase in primary astrocytes. J. Neuroimmunol. 64:1996;201-218.
20. Hooper D.C., Ohnishi S.H., Kean R., Numagami Y., Dietzschold B., Koprowski H. Local nitric oxide production in viral and autoimmune disease of the central nervous system. Proc. Natl. Acad. Sci. USA. 92:1995;5312-5316.
21. Huot A.E., Moore A.L., Roberts J.D., Hacker M.P. Nitric oxide modulates lymphocyte proliferation but not secretion of IL-2. Immunol. Invest. 22:1993;319-327.
22. Ialenti A., Ianaro A., Moncada S., Di Rosa M. Modulation of acute inflammation by endogenous nitric oxide. Eur. J. Pharmac. 211:1992;177-182.
23. Ianaro A., O'Donnell C.A., DiRosa M., Liew F.Y. A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice. Immunology. 82:1994;370-375.
24. G-monomethyl-L-arginine: a role for cyclic GMP. Blood. 74:1989;1885-1887.
25. Kennedy M.K., Torrance D.S., Picha K.S., Mohler K.M. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:1992;2496-2505.
26. Koedel U., Bernatowicz A., Paul R., Frei K., Fontana A., Pfister H.W. Experimental pneumococcal meningitis: cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide. Ann. Neurol. 37:1995;313-323.
27. Koprowski H., Zheng Y.M., Heber-Katz E., Fraser N., Rorke L., Fu Z.F., Hanlon D., Dietzschold B. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic disease. Proc. Natl. Acad. Sci. USA. 90:1993;3024-3027.
28. Lander H.M., Sehajpal P., Levine D.M., Novogrodsky A. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol. 150:1993;1509-1516.
29. Lin R.F., Lin T.S., Tilton R.G., Cross A.H. Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study. J. Exp. Med. 178:1993;643-648.
30. Lipton S.A., Choi Y.B., Pan Z.H., Lei S.Z., Chen H.V., Sucher N.J., Loscalzo J., Singel D.J., Stamler J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 364:1993;626-632.
31. Lowenstein C.J., Dinerman J.L., Snyder S.H. Nitric oxide: a physiologic messenger. Ann. Intern. Med. 120:1994;227-237.
32. MacMicking J.D., Willenborg D.O., Weidemann M.J., Rockett K.A., Cowden W.B. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: Enhancement by the soluble products of encephalitogenic T cells. J. Exp. Med. 176:1992;303-307.
33. Merrill J.E., Ignarro L.J., Sherman M.P., Melinek J., Lane T.E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:1993;2132-2141.
34. Merrill J.E., Kono D.H., Clayton J., Ando D.G., Hinton D.R., Hofman F.M. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc. Natl. Acad. Sci USA. 89:1992;574-578.
35. Mertin J., Stackpoole A. Anti-PGE antibodies inhibit in vivo development of cell-mediated immunity. Nature. 194:1981;456-458.
36. Misko T.P., Trotter J.L., Cross A.H. Mediation of inflammation by encephalitogenic cells: Cytokine induction of nitric oxide synthase and cyclooxygenase 2. J. Neuroimmunol. 61:1995;195-204.
37. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 38:1991;109-142.
38. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
39. - T lymphocytes. J. Immunol. 127:1981;1420-1423.
40. Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266:1991;244-250.
41. Radi R., Rodriguez M., Castro L., Telleri R. Inhibition of mitochondrial electron transport. Arch. Biochem. Biophys. 308:1994;89-95.
42. Raine C.S. Biology of disease. The analysis of autoimmune demyelination: its impact on multiple sclerosis. Lab. Invest. 50:1984;608-635.
43. Raine C.S., Cannella B., Duijvestijn A.M., Cross A.H. Homing to central nervous system vasculature by antigen specific lymphocytes. II. Lymphocyte-endothelial cell adhesion during the initial stages of autoimmune demyelination Lab. Invest. 63:1990;476-489.
44. Renno R., Lin J.Y., Piccirillo C., Antel J., Owens T. Cytokine production by cells in cerebrospinal fluid during experimental allergic encephalomyelitis in SJL/J mice. J. Neuroimmunol. 49:1994;1-7.
45. Ruddle N.H., Bergman C.M., McGrath K.M., Lingenheld E.G., Grunnet M.L., Padula S.J., Clark R.B. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1990;1193-1200.
46. Ruuls S.R., van der Linden S., Sontrop K., Huitinga I., Dijkstra C.D. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin. Exp. Immunol. 103:1996;467-474.
47. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA. 90:1993;7240-7244.
48. Selmaj K., Raine C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:1988;339-346.
49. Selmaj K., Raine C.S., Cross A.H. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol. 30:1991;694-700.
50. Sharief M.K., Phil M., Hentges R. Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N. Engl. J. Med. 325:1991;467-477.
51. Sicher S.C., Vazquez M.A., Lu C.Y. Inhibition of macrophage Ia expression by nitric oxide. J. Immunol. 153:1994;1293-1300.
52. Simmons M.L., Murphy S. Induction of nitric oxide synthase in glial cells. J. Neurochem. 59:1992;897-905.
53. Stuehr D.J., Marletta M.A. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma. J. Immunol. 139:1987;518-525.
54. Trotter J.L., Collins K.G., van der Veen R.C. Serum cytokine levels in chronic progressive multiple sclerosis: interleukin-2 levels parallel tumor necrosis factor-α levels. J. Neuroimmunol. 33:1991;29-36.
55. Vodovotz Y., Bogdan D., Paik J., Xie Q.-W., Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β J. Exp. Med. 178:1993;605-613.
56. Wei X., Charles I.G., Smith A., Ure J., Feng G., Huang F., Xu D., Muller W., Moncada S., Liew F.Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 375:1995;408-411.
57. Wink D.A., Kasprzak K.S., Maragos C.M., Elespuru R.K., Misra M., Dunams R., Cebula T.A., Koch W.H., Andrews A.W., Allen J.S., Keefer L.K. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science. 254:1991;1001-1003.
58. Xie Q.W., Nathan C. The high-output nitric oxide pathway: role and regulation. J. Leuk. Biol. 56:1994;576-582.
59. Xie Q.W., Cho H.J., Calacay J., Mumford R.A., Swiderek K.M., Lee T.D., Ding A., Trosos T., Nathan C.F. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science (Wash., DC). 256:1992;225-228.
60. Zhant J., Snyder S.H. Nitric oxide stimulates auto-ADP-ribosylation of glyceraldehyde-3- phosphate dehydrogenase. Proc. Natl. Acad. Sci USA. 89:1992;9382-9385.
61. Zhao W., Tilton R.G., Corbett J.A., McDaniel M.L., Misko T.P., Williamson J.R., Cross A.H., Hickey W.F. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of inducible nitric oxide synthase. J. Neuroimmunol. 64:1996;123-133.
62. Zielasek J., Jung S., Gold R., Liew F.Y., Toyka K.V., Hartung H.P. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J. Neuroimmunol. 58:1995;81-88.